- Pamidronate Uses, Side Effects Warnings - Drugs. com
Pamidronate: side effects, dosage, interactions, FAQs, reviews Used for: breast cancer, bone metastases, hypercalcemia, hypercalcemia of malignancy, osteolytic bone lesions of multiple myeloma, and more
- Pamidronate - StatPearls - NCBI Bookshelf
Pamidronate is a medication used in the management and treatment of moderate or severe hypercalcemia of malignancy, moderate to severe Paget disease of bone, osteolytic bone metastases of breast cancer, and osteolytic lesions of multiple myeloma It is in the bisphosphonate class of medications
- Pamidronate (intravenous route) - Mayo Clinic
Pamidronate injection is used to treat hypercalcemia (too much calcium in the blood) that may occur in patients with some types of cancer It is also used to treat Paget's disease of bone, multiple myeloma (tumors formed by the cells of the bone marrow), and certain types of bone metastases (the spread of cancer to the bones)
- Pamidronic acid - Wikipedia
Pamidronic acid or pamidronate disodium or APD (marketed as Aredia among others), is a nitrogen-containing bisphosphonate used to prevent osteoporosis It was patented in 1971 and approved for medical use in 1987
- Pamidronate (Aredia) - Uses, Side Effects, and More
Pamidronate slows the natural breakdown of your bones, which helps relieve the bone-damaging effects of conditions such as Paget’s Disease or cancer
- Pamidronate (Aredia): Uses Side Effects - Cleveland Clinic
PAMIDRONATE (pa mi DROE nate) slows calcium loss from bones It treats Paget's disease and high calcium levels in the blood from some kinds of cancer It may be used in other people at risk for bone loss
- Pamidronate Dosage Guide + Max Dose, Adjustments - Drugs. com
Detailed Pamidronate dosage information for adults Includes dosages for Paget's Disease, Osteolytic Bone Lesions of Multiple Myeloma, Hypercalcemia of Malignancy and more; plus renal, liver and dialysis adjustments
- Pamidronate: Package Insert Prescribing Info - Drugs. com
Pamidronate Disodium is a sterile bone-resorption inhibitor available in 30 mg and 90 mg vials for intravenous administration The pamidronate disodium obtained by combining pamidronic acid and sodium hydroxide is provided in a sterile, ready to use solution for injection
|